“Our findings support rivaroxaban as a viable alternative to warfarin, offering predictable dosing and eliminating the need for routine monitoring in patients with post-MI left ventricular ...

Research conducted by the Universitas Padjadjaran (Sumedang, Indonesia) focused on the measurement of vitamin K1 in various vegetables (specifically lettuce, cabbage, napa cabbage, and spinach) that ...

Or – on the contrary – samples are going to them unnecessarily. Xprecia Prime checks the dosage of vitamin K antagonists (such as warfarin). Too much efficacy means there’s a risk of dangerous ...

CHICAGO, IL—Patients who develop thrombus in the left ventricle following myocardial infarction fare equally well when treated with rivaroxaban (Xarelto; Bayer/Janssen) as they do with warfarin, the ...

Clinical question: Is there an association between baseline dietary sodium intake and clinical outcomes in heart failure? Background: Dietary sodium restriction is common advice for patients with ...

Clinical question: Does patient sex influence opioid prescription patterns during hospitalization and at discharge on general medicine services? Background: Clinicians may have sex- and gender-based ...

CHICAGO — Extended therapy with reduced-dose apixaban is just as effective as the high dose in preventing recurrent venous thromboembolism (VTE) in patients with active cancer who completed at ...

Extended treatment with low-dose apixaban was noninferior to a full dose for preventing cancer-related VTE. Perspective from Geoffrey Barnes, MD, MSc CHICAGO — For patients with cancer requiring ...

Patients were randomly assigned to be treated with either 5 mg (2.5mg twice daily; the reduced-dose group) or 10 mg (5 mg twice daily; the full-dose group) of apixaban for an additional 12 months.

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...

CHICAGO, IL—For patients with active cancer who’ve had venous thromboembolism (VTE), 12-month extended anticoagulation with reduced-dose apixaban is noninferior to the full dose at preventing ...